focus
Previous article:
Dobbs anniversary: the lost opportunity of abortion as health care
Next article: Eli Lilly reports tirzepatide MASH success during Q4 earnings
Next article: Eli Lilly reports tirzepatide MASH success during Q4 earnings
hotspot
hotspot
-
Websites selling Wegovy, Zepbound ingredients targeted by FDA
2025-09-27 12:20 -
Tome Biosciences co
2025-09-27 11:52 -
Eli Lilly reports tirzepatide MASH success during Q4 earnings
2025-09-27 11:40 -
Juul documents reveal insider tactics on political lobbying
2025-09-27 11:22 -
World's first CRISPR
2025-09-27 11:08 -
Ransomware attacks on hospitals: Study outlines patient impact
2025-09-27 11:08